FDA Inspection
Department of Defense - NavyDepartment of Defense - Navy – FDA Inspection, Mar 4, 2026
Record Details
This FDA Inspection record concerns Department of Defense - Navy, with an inspection on March 4, 2026, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · b762dab4-2625-4da0-b8ae-9ae8ddc35d97
Inspection Facts
- Inspection number
- 1305570
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 630.10(g)(1)Proof Of Identity
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Navy
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 20, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 16, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 16, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 28, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 30, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Navy
- FDA Inspection 1204978 - 2023-04-20
- FDA Inspection 1093450 - 2019-05-16
- FDA Inspection 986414 - 2016-09-16
- FDA Inspection 841461 - 2013-06-28
- FDA Inspection 745751 - 2011-08-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.